USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 179 filers reported holding USANA HEALTH SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $71,250,104 | -7.1% | 1,574,936 | -0.4% | 0.00% | -50.0% |
Q1 2024 | $76,712,062 | -9.6% | 1,581,692 | -0.1% | 0.00% | 0.0% |
Q4 2023 | $84,834,972 | -7.6% | 1,582,742 | +1.0% | 0.00% | 0.0% |
Q3 2023 | $91,852,537 | -4.7% | 1,567,182 | +2.5% | 0.00% | 0.0% |
Q2 2023 | $96,366,032 | -0.7% | 1,528,649 | -0.9% | 0.00% | 0.0% |
Q1 2023 | $97,051,806 | +18.9% | 1,542,954 | +0.5% | 0.00% | 0.0% |
Q4 2022 | $81,657,213 | -1.6% | 1,534,910 | +3.7% | 0.00% | 0.0% |
Q3 2022 | $82,993,000 | -23.4% | 1,480,683 | -1.1% | 0.00% | -33.3% |
Q2 2022 | $108,352,000 | -9.7% | 1,497,383 | -0.9% | 0.00% | 0.0% |
Q1 2022 | $120,037,000 | -20.9% | 1,510,852 | +0.8% | 0.00% | 0.0% |
Q4 2021 | $151,672,000 | +7.3% | 1,498,731 | -2.3% | 0.00% | -25.0% |
Q3 2021 | $141,371,000 | -7.5% | 1,533,308 | +2.8% | 0.00% | 0.0% |
Q2 2021 | $152,811,000 | +4.7% | 1,491,859 | -0.2% | 0.00% | 0.0% |
Q1 2021 | $145,914,000 | +32.6% | 1,495,013 | +4.7% | 0.00% | +33.3% |
Q4 2020 | $110,073,000 | +7.3% | 1,427,660 | +2.5% | 0.00% | 0.0% |
Q3 2020 | $102,608,000 | +2.9% | 1,393,194 | +2.6% | 0.00% | -25.0% |
Q2 2020 | $99,713,000 | +23.9% | 1,357,935 | -2.5% | 0.00% | +33.3% |
Q1 2020 | $80,479,000 | -23.4% | 1,393,348 | +4.1% | 0.00% | -25.0% |
Q4 2019 | $105,094,000 | +14.8% | 1,337,925 | -0.0% | 0.00% | +33.3% |
Q3 2019 | $91,525,000 | -19.8% | 1,338,291 | -6.8% | 0.00% | -25.0% |
Q2 2019 | $114,051,000 | -7.1% | 1,435,868 | -1.9% | 0.00% | -20.0% |
Q1 2019 | $122,803,000 | -22.8% | 1,464,217 | +8.3% | 0.01% | -28.6% |
Q4 2018 | $159,107,000 | +5.9% | 1,351,456 | +8.5% | 0.01% | +16.7% |
Q3 2018 | $150,182,000 | +15.8% | 1,245,807 | +10.7% | 0.01% | +20.0% |
Q2 2018 | $129,724,000 | +46.1% | 1,125,098 | +8.9% | 0.01% | +25.0% |
Q1 2018 | $88,787,000 | +15.5% | 1,033,614 | -0.5% | 0.00% | +33.3% |
Q4 2017 | $76,901,000 | +31.2% | 1,038,490 | +2.2% | 0.00% | 0.0% |
Q3 2017 | $58,605,000 | -6.7% | 1,015,674 | +3.7% | 0.00% | 0.0% |
Q2 2017 | $62,801,000 | +14.2% | 979,726 | +2.6% | 0.00% | 0.0% |
Q1 2017 | $54,984,000 | -2.1% | 954,590 | +4.0% | 0.00% | 0.0% |
Q4 2016 | $56,177,000 | -13.6% | 917,935 | +95.4% | 0.00% | -25.0% |
Q3 2016 | $64,983,000 | +10.3% | 469,697 | -11.2% | 0.00% | 0.0% |
Q2 2016 | $58,915,000 | -25.4% | 528,719 | -18.7% | 0.00% | -20.0% |
Q1 2016 | $78,959,000 | -3.3% | 650,288 | +1.7% | 0.01% | 0.0% |
Q4 2015 | $81,663,000 | -3.1% | 639,243 | +1.6% | 0.01% | +66.7% |
Q3 2015 | $84,309,000 | +3.8% | 629,034 | +5.8% | 0.00% | -40.0% |
Q2 2015 | $81,214,000 | +48.5% | 594,277 | +20.8% | 0.01% | +25.0% |
Q1 2015 | $54,682,000 | +25.5% | 492,101 | +15.9% | 0.00% | +33.3% |
Q4 2014 | $43,569,000 | +48.2% | 424,688 | +6.4% | 0.00% | +50.0% |
Q3 2014 | $29,405,000 | -14.8% | 399,196 | -9.6% | 0.00% | -33.3% |
Q2 2014 | $34,523,000 | -9.1% | 441,810 | -12.4% | 0.00% | 0.0% |
Q1 2014 | $37,997,000 | +1.1% | 504,328 | +1.4% | 0.00% | 0.0% |
Q4 2013 | $37,581,000 | -9.5% | 497,228 | +4.0% | 0.00% | -25.0% |
Q3 2013 | $41,510,000 | +31.8% | 478,273 | +9.9% | 0.00% | +33.3% |
Q2 2013 | $31,489,000 | – | 435,049 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |